Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder-Reference-Cited by-同舟云学术

Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder

Published:2023-08-16 Issue:10 Volume:62 Page:1427-1443
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

Björnsson Marcus,Acharya Chayan,Strandgården Kerstin,Tiberg Fredrik

Funder

Camurus AB

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40262-023-01288-6.pdf

Reference49 articles.

2. Volkow ND, Blanco C. Medications for opioid use disorders: Clinical and pharmacological considerations. J Clin Invest. 2020;130(1):10–3. https://doi.org/10.1172/JCI134708.

3. American Psychiatric Association. Substance-related and addictive disorders. Diagnostic and statistical manual of mental disorders: Dsm-5-tr. 5th Edition, Text. Revision. Washington, DC: American Psychiatric Association; 2022. p. 543–665.

4. Lintzeris N, Dunlop AJ, Haber PS, Lubman DI, Graham R, Hutchinson S, Arunogiri S, Hayes V, Hjelmström P, Svedberg A, Peterson S, Tiberg F. Patient-reported outcomes of treatment of opioid dependence with weekly and monthly subcutaneous depot vs daily sublingual buprenorphine: a randomized clinical trial. JAMA Netw. 2021;4(5): e219041. https://doi.org/10.1001/jamanetworkopen.2021.9041.

5. Jones AK, Ngaimisi E, Gopalakrishnan M, Young MA, Laffont CM. Population pharmacokinetics of a monthly buprenorphine depot injection for the treatment of opioid use disorder: a combined analysis of Phase ii and Phase iii trials. Clin Pharmacokinet. 2021;60(4):527–40. https://doi.org/10.1007/s40262-020-00957-0.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA;Drugs & Therapy Perspectives;2024-02